-
Product Insights
NewNet Present Value Model: Scholar Rock Holding Corp’s SRK-181
Empower your strategies with our Net Present Value Model: Scholar Rock Holding Corp's SRK-181 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Linavonkibart in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linavonkibart in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linavonkibart in Non-Small Cell Lung Cancer Drug Details: SRK-181 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Linavonkibart in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linavonkibart in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linavonkibart in Head And Neck Squamous...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SRK-181 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SRK-181 in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SRK-181 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SRK-181 in Ovarian Cancer report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SRK-181 in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SRK-181 in Oropharyngeal Cancer report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Apitegromab in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Apitegromab in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apitegromab in Obesity Drug Details: Apitegromab (SRK-015) is under development for the treatment...
-
Product Insights
Vito-Poshtova SRK – 96b-Zvenyhorodska Street Preschool – Kyiv City
Equip yourself with the essential tools needed to make informed and profitable decisions with our Vito-Poshtova SRK - 96b-Zvenyhorodska Street Preschool - Kyiv City report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Report Bundle
53% offFuture of Construction in the Middle East and Africa – Report Bundle (7 Reports)
Future of Construction in MEA Bundle Overview The construction industry plays a significant role in the development of a country. Governments across many countries are making investments to revive this sector after the COVID-19 pandemic’s impact, as it will generate employment. In the long run, this will help in the overall growth of the economy. Each report within the bundle allows you to access in-depth analysis of the construction industry of the respective countries. The reports provide – Historical (2018-2022)...